Under construction – not a live service
Sign in
Taking people in EgyptNo phase

Ovarian reserve after surgery to remove endometriosis cysts or other benign ovarian cysts

Compares ovarian reserve after laparoscopic cyst removal in women with endometriosis or other ovarian cysts.

Plain-language title generated from the registry record
Registry title: Ovarian Reserve After Laparoscopic Cystectomy for Endometriotic and Non-Endometriotic Cysts

Key facts

Where
Banhā, EgyptSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 45 years old?

Source: NCT07686783, who can take part

Where in Egypt

  • Benha Univesity HospitalBanhā, EgyptTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Benha University
Trial code
NCT07686783
Record updated
30 September 2026
Original description
We will conduct this study to estimate the effect of laparoscopic cystectomy on ovarian reserve in endometriotic cysts versus non-endometriotic cysts.Read full original descriptionShow less

Ovarian Reserve After Laparoscopic Cystectomy for Endometriotic and Non-Endometriotic Cysts: A Comparative Prospective Cohort Study

We will conduct this study to estimate the effect of laparoscopic cystectomy on ovarian reserve in endometriotic cysts versus non-endometriotic cysts.

Inclusion: Female patients aged 18-45 years; Ovarian cyst measuring 6-15 cm in diameter, confirmed by transvaginal ultrasound or MRI; Cyst is persistent for more than 3 months if asymptomatic, OR any symptomatic cyst regardless of duration of diagnosis; Serum anti-Müllerian hormone (AMH) level ≥ 2 ng/mL, measured within 1 month preoperatively; Willingness to participate and provide written informed consent.

Exclusion: Previous history of ovarian surgery; Current use of hormonal contraceptives or hormonal therapy within 3 months prior to enrollment; Clinical or ultrasonic suspicion of ovarian malignancy; History of pelvic irradiation or chemotherapy; Known endocrine disorders affecting ovarian function (e.g., PCOS, premature ovarian insufficiency, thyroid dysfunction, hyperprolactinemia); Presence of severe systemic disease that contraindicates surgery or general anesthesia; Ovarian cyst associated with pregnancy; Refusal to participate or inability to provide informed consent.

ClinicalTrials.gov NCT07686783